Table 2.

Demographic and clinical characteristics

Total (N = 41)
Sex
    Female15
    Male26
Age, y
    18 to <6533
    ≥658
    Median (range)56.0 (29-75)
Eastern Cooperative Oncology Group status
    015
    124
    22
Histology
    Leiomyosarcoma11
    Liposarcoma20
    Other10
Primary tumor site
    Abdomen/pelvis, other2
    Abdomen/pelvic wall2
    Chest wall1
    Chest, other7
    Face1
    Lower extremity11
    Neck1
    Retroperitoneal15
    Uterus1
Previous therapy
    Systemic*7
    Surgery39
    Radiotherapy15
  • * Previous systemic therapies included gemcitabine, carboplatin, cisplatin, docetaxel, doxorubicin, etoposide, fluorouracil, imatinib mesylate, melphalan, and tumor necrosis factor receptor IgG1.